Substance Use, Demographic and Socioeconomic Factors Are Independently Associated With Postpartum HIV Care Engagement in the Southern United States, 1999-2016.

HIV engagement in care postpartum retention in care viral suppression

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 11 01 2019
accepted: 14 01 2019
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 23 2 2019
Statut: epublish

Résumé

Retention in care (RIC) and viral suppression (VS) are associated with reduced HIV transmission and mortality. Studies addressing postpartum engagement in HIV care have been limited by small sample size, short follow-up, and a lack of data from the Southeast United States. HIV-positive adult women with ≥1 prenatal visit at the Vanderbilt Obstetrics Comprehensive Care Clinic from 1999 to 2015 were included. Poor RIC was defined as not having ≥2 encounters per year, ≥90 days apart; poor VS was a viral load >200 copies/mL. Modified Poisson regression was used to estimate adjusted relative risks (aRRs) of poor postpartum RIC and VS. Among 248 women over 2070 person-years of follow-up, 37.6% person-years had poor RIC and 50.4% lacked VS. Prenatal substance use was independently associated with poor RIC (aRR, 1.40; 95% confidence interval [CI], 1.08-1.80) and poor VS (aRR, 1.20; 95% CI, 1.04-1.38), and lack of VS at enrollment was associated with poor RIC (aRR, 1.64; 95% CI, 1.15-2.35) and poor VS (aRR, 1.59; 95% CI, 1.30-1.94). Hispanic women were less likely and women with lower educational attainment were more likely to have poor RIC. Women >30 years of age and married women were less likely to have poor VS. In this population of women in prenatal care at an HIV primary medical home in Tennessee, women with prenatal substance use and a lack of VS at enrollment into prenatal care were at greater risk of poor RIC and lack of VS postpartum. Interventions aimed at improving postpartum engagement in HIV care among these high-risk groups are needed.

Sections du résumé

BACKGROUND BACKGROUND
Retention in care (RIC) and viral suppression (VS) are associated with reduced HIV transmission and mortality. Studies addressing postpartum engagement in HIV care have been limited by small sample size, short follow-up, and a lack of data from the Southeast United States.
METHODS METHODS
HIV-positive adult women with ≥1 prenatal visit at the Vanderbilt Obstetrics Comprehensive Care Clinic from 1999 to 2015 were included. Poor RIC was defined as not having ≥2 encounters per year, ≥90 days apart; poor VS was a viral load >200 copies/mL. Modified Poisson regression was used to estimate adjusted relative risks (aRRs) of poor postpartum RIC and VS.
RESULTS RESULTS
Among 248 women over 2070 person-years of follow-up, 37.6% person-years had poor RIC and 50.4% lacked VS. Prenatal substance use was independently associated with poor RIC (aRR, 1.40; 95% confidence interval [CI], 1.08-1.80) and poor VS (aRR, 1.20; 95% CI, 1.04-1.38), and lack of VS at enrollment was associated with poor RIC (aRR, 1.64; 95% CI, 1.15-2.35) and poor VS (aRR, 1.59; 95% CI, 1.30-1.94). Hispanic women were less likely and women with lower educational attainment were more likely to have poor RIC. Women >30 years of age and married women were less likely to have poor VS.
CONCLUSIONS CONCLUSIONS
In this population of women in prenatal care at an HIV primary medical home in Tennessee, women with prenatal substance use and a lack of VS at enrollment into prenatal care were at greater risk of poor RIC and lack of VS postpartum. Interventions aimed at improving postpartum engagement in HIV care among these high-risk groups are needed.

Identifiants

pubmed: 30793010
doi: 10.1093/ofid/ofz023
pii: ofz023
pmc: PMC6372056
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofz023

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113438
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002244
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI110527
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI131895
Pays : United States

Références

Biometrics. 2001 Mar;57(1):120-5
pubmed: 11252586
AIDS. 2003 Aug 15;17(12):1741-51
pubmed: 12891060
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Curr HIV/AIDS Rep. 2005 Nov;2(4):177-83
pubmed: 16343375
JAMA. 2008 Aug 6;300(5):555-70
pubmed: 18677028
Public Health Rep. 2009 Nov-Dec;124(6):850-60
pubmed: 19894428
AIDS Patient Care STDS. 2010 Aug;24(8):515-20
pubmed: 20672971
J Womens Health (Larchmt). 2010 Oct;19(10):1863-7
pubmed: 20831428
Am J Public Health. 2012 Nov;102(11):2129-34
pubmed: 22994194
Am J Epidemiol. 2013 Sep 1;178(5):819-28
pubmed: 23785113
AIDS Care. 2014;26(3):351-9
pubmed: 23944833
AIDS Patient Care STDS. 2014 May;28(5):248-53
pubmed: 24720630
AIDS Patient Care STDS. 2015 Mar;29(3):126-32
pubmed: 25612217
Clin Infect Dis. 2015 Dec 15;61(12):1880-7
pubmed: 26265499
AIDS. 2016 Aug 24;30(13):2117-24
pubmed: 27465279
PLoS One. 2016 Aug 11;11(8):e0160775
pubmed: 27513953
Pediatr Infect Dis J. 2017 Jan;36(1):66-71
pubmed: 27749662
Int J Environ Res Public Health. 2017 Mar 09;14(3):
pubmed: 28282947
AIDS. 2018 Jan 14;32(2):133-142
pubmed: 29194122
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849
pubmed: 30091969
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049

Auteurs

Cassandra Oliver (C)

Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee.

Peter F Rebeiro (PF)

Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Mary J Hopkins (MJ)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Beverly Byram (B)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Lavenia Carpenter (L)

Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee.

Kate Clouse (K)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.

Jessica L Castilho (JL)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

William Rogers (W)

Covance, Clinical Trials, Indianapolis, Indiana.

Megan Turner (M)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Sally S Bebawy (SS)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

April C Pettit (AC)

Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Classifications MeSH